✦ LIBER ✦

Effects of Sun Ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial

✍ Scribed by Jong-Hoon Kim; Chan Yong Park; Sung-Jae Lee

Book ID: 108848952
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 67 KB
Volume: 31
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2006.00740.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab treatment results in signific

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial

✍ S.R. Feldman; K.B. Gordon; M. Bala; R. Evans; S. Li; L.T. Dooley; C. Guzzo; K. P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

✍ J.W.A.S. Sander; P.N. Patsalos; J.R. Oxley; M.J. Hamilton; W.C. Yuen 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 616 KB

Randomised clinical trial: rifaximin imp

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy – a double-blind placebo-controlled study

✍ A. Sanyal; Z. M. Younossi; N. M. Bass; K. D. Mullen; F. Poordad; R. S. Brown; R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Discontinuation of proton pump inhibitor

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial

✍ E. BJÖRNSSON; H. ABRAHAMSSON; M. SIMRÉN; N. MATTSSON; C. JENSEN; P. AGERFORZ; A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This

Short report: a double-blind placebo-con

Short report: a double-blind placebo-controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects

✍ L. RASMUSSEN; E. ØTER-JØRGENSEN; N. QVIST; K. KRAGLUND; C. HOVENDAL; S. A. PEDER 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB